Industry Supported Education - Oncology Nurse Advisor

Industry Supported Education

Supporting Resectable Non-Small Cell Lung Cancer Patients Through Diagnosis and Treatment Selection

Content Sponsored by AstraZeneca Historically, surgery has been the mainstay of treatment for patients with early-stage non-small cell lung cancer (NSCLC). Those who are diagnosed early enough to be eligible for surgery undergo complete tumor resection, and, if indicated, receive adjuvant treatment such as chemotherapy.   But even after surgery and adjuvant chemotherapy when indicated,…